Mark Tyndall

Mark Tyndall serves as Executive Vice President, Chief Legal Officer, and Corporate Secretary. Mr. Tyndall has executive responsibility for all legal functions and serves as the primary liaison to the Board of Directors. His responsibilities also include leadership of the company’s Government Affairs and Patient Advocacy functions. 

From February 2021 to August 2022, Mr. Tyndall served as the company’s Senior Vice President and U.S. General Counsel, overseeing U.S. and international commercial legal teams, corporate litigation and investigations, legal operations, and corporate privacy, while also managing the Government Affairs team. Other prior roles at our company include Senior Vice President of Government Affairs & Chief Counsel of Litigation from February 2019 to February 2021 and Vice President of Government Affairs, Policy and Patient Advocacy from June 2014 to February 2019. 

Before joining the Company, Mr. Tyndall led Global Policy and Public Affairs for Bayer Healthcare’s consumer health division from January 2013 to June 2014. He previously practiced healthcare and political law at Sidley Austin LLP in Washington, D.C., where his focus included healthcare regulatory issues, fraud and abuse matters, and legislative policy. Earlier in his career, he served as a professional staff member of the U.S. Senate Committee on Agriculture, Nutrition and Forestry. 

Mr. Tyndall holds a Juris Doctor from George Washington University Law School, a Master’s in Public Policy from the College of William and Mary, and a Bachelor of Arts in Economics from Christopher Newport University. He also completed the International Human Rights Law Summer Program at the University of Oxford, New College.